<DOC>
	<DOCNO>NCT02587728</DOCNO>
	<brief_summary>Carpal tunnel early manifestation amyloidosis significant minority patient . This specimen collection protocol allow investigator screen patient carpal tunnel syndrome amyloidosis .</brief_summary>
	<brief_title>Carpal Tunnel/Amyloidosis Blood Sample Study</brief_title>
	<detailed_description>The investigator propose assess high risk population patient , carpal tunnel syndrome , systematically assess Amyloid Light-chain ( AL ) amyloidosis Transthyretin-Related Amyloidosis ( ATTR ) simple laboratory blood test . The combination serum immunofixation electrophoresis together serum free light chain ( FLC ) assay approach 100 % sensitivity identify monoclonal protein underlie illness patient AL amyloidosis . In addition , test transthyretin gene mutation allow investigator identify patient ATTR . The investigator believe simple screening panel ( serum immunofixation serum FLC assay transthyretin mutation analysis ) may allow investigator identify patient early course disease , point investigator intervene effective treatment spare patient significant amount morbidity mortality .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carpal Tunnel Syndrome</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>1 . Patients symptoms sign `` highly suggestive '' consistent `` possible '' carpal tunnel syndrome . 2 . Patients electrographic confirmation median neuropathy wrist 3 . Age â‰¥18 year 4 . Ability understand willingness sign write informed consent document . 1 . Pregnant woman 2 . Patients receive hemodialysis 3 . Known amyloidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Carpal Tunnel Syndrome</keyword>
	<keyword>Amyloidosis</keyword>
</DOC>